top of page
iPharmaCenter
News | Blogs | Healthcare | Consulting
Contact:
info@ipharmacenter.com
ipharmacenter Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
ipharmacenter
Consulting services
Home
Pharma
North America
US FDA Approvals
Canada Drug Healthcare News
APAC
China Drug Approvals
India Drug Approvals
APAC - Drug Approvals
Japan Drug Approvals | Healthcare
Europe
EMA News
LACAM
Brazil - Drug approvals
Healthcare News
US Healthcare News
US Payer News
APAC - Healthcare News
Europe Healthcare News
Lacam Healthcare News
Healthcare Policies
Disease News
Immunology
Oncology
Infections_Vaccines
Cardiovascular
Kidney Diseases
Metabolic Diseases
Women Health
Neurology
Conferences
Others
Respiratory syncytial virus | News | Updates | iPharmaCenter
ExpressScripts is optimistic about the RSV season with the approval of new vaccines In May 2023, the U.S. Food & Drug Administration...
HPV News | Updates | iPharmaCenter
Merck has released a comprehensive publication on the long-term follow-up (LTFU) data for Gardasil 9 (Human Papillomavirus 9-valent...
Meningococcal infection | iPharmaCenter
GlaxoSmithKline (GSK) has presented positive results from the phase III trial of its MenABCWY vaccine candidate at the European Society...
HIV News and media blogs | Viiv's Apretude approved in the US for HIV prevention
Janssen to discontinue HIV vaccine Phase 3 trial. Janssen Pharmaceuticals and Global Partners announced their intention to discontinue...
bottom of page